Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity during Antidepressant Treatment

Neuropsychopharmacology

Volumn 42, Issue 10, 2017, Pages 2043-2051

  Lopez, Juan Pablo ^a,b   Pereira, Fabricio ^c   Richard Devantoy, Stéphane ^a,d   Berlim, Marcelo ^a,d   Chachamovich, Eduardo ^a,d   Fiori, Laura M ^a,d   Niola, Paola ^e   Turecki, Gustavo ^a,d   Jollant, Fabrice ^a,d,f  

^a MCGILL UNIVERSITY   (Canada)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIV MONTPELLIER   (France)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f Hospital of Nîmes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESVENLAFAXINE; GLUTAMIC ACID; MICRORNA; MICRORNA 1202; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; MIRN1202 MICRORNA, HUMAN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN RADIOGRAPHY; CINGULATE GYRUS; CLAUSTRUM; CLINICAL ARTICLE; CONNECTOME; DEFAULT MODE NETWORK; DORSOMEDIAL PREFRONTAL CORTEX; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL CONNECTIVITY; FUSIFORM GYRUS; HEMISPHERE; HUMAN; INFERIOR FRONTAL GYRUS; INFERIOR TEMPORAL GYRUS; INSULA; MAJOR DEPRESSION; MALE; MIDDLE FRONTAL GYRUS; MIDDLE OCCIPITAL GYRUS; MIDDLE TEMPORAL GYRUS; NEUROIMAGING; NEUROPHARMACOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PHARMACOGENETICS; POSTERIOR CINGULATE; PRECUNEUS; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUTAMEN; SUBCALLOSAL GYRUS; SUPERIOR FRONTAL GYRUS; SUPERIOR TEMPORAL GYRUS; UNCUS; BLOOD; BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; DRUG EFFECTS; INHIBITION (PSYCHOLOGY); MOTOR ACTIVITY; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REST; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; DESVENLAFAXINE SUCCINATE; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MALE; MICRORNAS; MOTOR ACTIVITY; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; REST; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 85013469541     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2017.9     Document Type: Article

References (44)

1. Balthazar ML, Pereira FR, Lopes TM, da Silva EL, Coan AC, Campos BM, et al (2014). Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp 35: 1237-1246.
2. Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O (2010). miR-16 targets the serotonin transporter: A new facet for adaptive responses to antidepressants. Science 329: 1537-1541.
3. Beckmann CF, Smith SM (2004). Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 23: 137-152.
4. Bocchio-Chiavetto L, Maffioletti E, Bettinsoli P, Giovannini C, Bignotti S, Tardito D, et al (2013). Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol 23: 602-611.
5. Chen H, Wang N, Burmeister M, McInnis MG (2009). MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol 12: 975-981.
6. Cox RW (2012). AFNI: What a long strange trip it's been. Neuroimage 62: 743-747.
7. Cruceanu C, Lopez JP, Tsai WT, Turecki G (2016). Dysregulation of the glutamatergic receptors after antidepressant treatment in human neural progenitor cells. Mol Psychiatry (epub ahead of print).
8. Delaveau P, Jabourian M, Lemogne C, Guionnet S, Bergouignan L, Fossati P (2011). Brain effects of antidepressants in major depression: A meta-analysis of emotional processing studies. J Affect Disord 130: 66-74.
9. Dichter GS, Gibbs D, Smoski MJ (2015). A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. J Affect Disord 172: 8-17.
10. Duncan NW, Wiebking C, Tiret B, Marjanska M, Hayes DJ, Lyttleton O, et al (2013). Glutamate concentration in the medial prefrontal cortex predicts resting-state cortical-subcortical functional connectivity in humans. PLoS One 8: E60312.
11. Dutta A, McKie S, Deakin JF (2014). Resting state networks in major depressive disorder. Psychiatry Res 224: 139-151.
12. First MB, Spitzer RL, Gibbon M, Williams JBW (2012). Structured Clinical Interview for DSM-IV® Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. American Psychiatric Publishing: New York.
13. Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ (2008). A metaanalytic study of changes in brain activation in depression. Hum Brain Mapp 29: 683-695.
14. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, et al (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61: 877-889.
15. Fu CH, Costafreda SG, Sankar A, Adams TM, Rasenick MM, Liu P, et al (2015). Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine. BMC Psychiatry 15: 82.
16. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al (2008). Serum microRNAs are promising novel biomarkers. PLoS One 3: E3148.
17. Gray AL, Hyde TM, Deep-Soboslay A, Kleinman JE, Sodhi MS (2015). Sex differences in glutamate receptor gene expression in major depression and suicide. Mol Psychiatry 20: 1057-1068.
18. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
19. Iglesias JE, Liu CY, Thompson PM, TU Z (2011). Robust brain extraction across datasets and comparison with publicly available methods. IEEE Trans Med Imaging 30: 1617-1634.
20. Issler O, Haramati S, Paul ED, Maeno H, Navon I, Zwang R, et al (2014). MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 83: 344-360.
21. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012). FSL. Neuroimage 62: 782-790.
22. Jollant F, Richard-Devantoy S, Ding Y, Turecki G, Bechara A, Near J (2016). Prefrontal inositol levels and implicit decision-making in healthy individuals and depressed patients. Eur Neuropsychopharmacol 26: 1255-1263.
23. Kaiser S, Unger J, Kiefer M, Markela J, Mundt C, Weisbrod M (2003). Executive control deficit in depression: Event-related potentials in a Go/Nogo task. Psychiatry Res 122: 169-184.
24. Lau MA, Christensen BK, Hawley LL, Gemar MS, Segal ZV (2007). Inhibitory deficits for negative information in persons with major depressive disorder. Psychol Med 37: 1249-1259.
25. Lopez JP, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B, et al (2014). miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med 20: 764-768.
26. Lorenz RC, Gleich T, Buchert R, Schlagenhauf F, Kühn S, Gallinat J (2015). Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum. Hum Brain Mapp 36: 4031-4040.
27. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S (2008). A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 17: 3030-3042.
28. Mulders PC, van Eijndhoven PF, Schene AH, Beckmann CF, Tendolkar I (2015). Resting-state functional connectivity in major depressive disorder: A review. Neurosci Biobehav Rev 56: 330-344.
29. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
30. Murrough JW, Abdallah CG, Anticevic A, Collins KA, Geha P, Averill LA, et al (2016). Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Hum Brain Mapp 37: 3214-3223.
31. O'Connor RM, Dinan TG, Cryan JF (2012). Little things on which happiness depends: MicroRNAs as novel therapeutic targets for the treatment of anxiety and depression. Mol Psychiatry 17: 359-376.
32. Oldfield RC (1971). The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 9: 97-113.
33. Pereira FR, Alessio A, Sercheli MS, Pedro T, Bilevicius E, Rondina JM, et al (2010). Asymetricla hippocampal connectivity in mesial temporal lobe epilepsy: Evidence from resting state fMRI. BMC Neurosci 11: 66.
34. Phillips ML, Chase HW, Sheline YI, Etkin A, Almeida JR, Deckersbach T, et al (2015). Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: Neuroimaging approaches. Am J Psychiatry 172: 124-138.
35. Richard-Devantoy S, Ding Y, Lepage M, Turecki G, Jollant F (2016). Cognitive inhibition in depression and suicidal behavior: A neuroimaging study. Psychol Med 46: 933-944.
36. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR, D report. Am J Psychiatry 163: 1905-1917.
37. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, et al (2004). Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 22: 409-418.
38. Shirer WR, Ryali S, Rykhlevskaia E, Menon V, Greicius MD (2012). Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb Cortex 22: 158-165.
39. Vaisvaser S, Modai S, Farberov L, Lin T, Sharon H, Gilam A, et al (2016). Neuro-epigenetic indications of acute stress response in humans: The case of microRNA-29c. PLoS One 11: E0146236.
40. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
41. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13: 423-433.
42. Xu C, Liu X, Song X, Gao Q, Cheng L, Wang L, et al (2016). Aberrant resting state in microRNA-30e rat model of cognitive impairment. Neuroreport 27: 809-817.
43. Zhang X, Tang Y, Maletic-Savatic M, Sheng J, Zhang X, Zhu Y, et al (2016). Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study. J Affect Disord 201: 153-161.
44. Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y, et al (2009). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34: 1395-1405.